Similar articles for PMID: 5170695

Year	Number of Results
1938	1
1939	1
1946	1
1950	1
1954	1
1962	1
1963	2
1964	1
1965	1
1966	2
1968	1
1970	1
1971	2
1972	1
1975	2
1976	1
1977	5
1978	1
1979	2
1980	1
1982	1
1983	3
1988	3
1989	2
1990	4
1991	9
1992	2
1993	2
1994	6
1995	2
1996	3
1997	3
1998	1
2000	1
2002	1
2004	1
2008	1
2011	1
2012	2
2013	1
2014	1
2015	10
2016	1
2019	1
2020	1
2021	0

1

The measles epidemic in Calgary 1969-70; the protective effect of vaccination for the individual and the community.

O'Neil AE. O'Neil AE. Can Med Assoc J. 1971 Oct 23;105(8):819-25. Can Med Assoc J. 1971. PMID: 5170695 Free PMC article.

2

Immunization of six-month-old infants with different doses of Edmonston-Zagreb and Schwarz measles vaccines.

Markowitz LE, Sepulveda J, Diaz-Ortega JL, Valdespino JL, Albrecht P, Zell ER, Stewart J, Zarate ML, Bernier RH. Markowitz LE, et al. N Engl J Med. 1990 Mar 1;322(9):580-7. doi: 10.1056/NEJM199003013220903. N Engl J Med. 1990. PMID: 2304505 Free article. Clinical Trial.

3

Trial of high-dose Edmonston-Zagreb measles vaccine in Guinea-Bissau: protective efficacy.

Aaby P, Jensen TG, Hansen HL, Kristiansen H, Thårup J, Poulsen A, Sodemann M, Jakobsen M, Knudsen K, Clotilde da Silva M, et al. Aaby P, et al. Lancet. 1988 Oct 8;2(8615):809-11. doi: 10.1016/s0140-6736(88)92780-8. Lancet. 1988. PMID: 2902263 Clinical Trial.

4

Edmonston-Zagreb strain of measles vaccine: epidemiologic evaluation in Yugoslavia.

Ikić DM. Ikić DM. Rev Infect Dis. 1983 May-Jun;5(3):558-63. Rev Infect Dis. 1983. PMID: 6879014

5

The effect of epidemic measles on immunization rates.

Goldstein KP, Philipson TJ, Joo H, Daum RS. Goldstein KP, et al. JAMA. 1996 Jul 3;276(1):56-8. JAMA. 1996. PMID: 8667540

6

Measles control in developing and developed countries: the case for a two-dose policy.

Tulchinsky TH, Ginsberg GM, Abed Y, Angeles MT, Akukwe C, Bonn J. Tulchinsky TH, et al. Bull World Health Organ. 1993;71(1):93-103. Bull World Health Organ. 1993. PMID: 8440043 Free PMC article. Review.

7

The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program.

Peltola H, Heinonen OP, Valle M, Paunio M, Virtanen M, Karanko V, Cantell K. Peltola H, et al. N Engl J Med. 1994 Nov 24;331(21):1397-402. doi: 10.1056/NEJM199411243312101. N Engl J Med. 1994. PMID: 7969278 Free article.

8

Vaccination against measles. Clinical trial of live measles vaccine given alone and live vaccine preceded by killed vaccine. Third report to the Medical Research Council by the Measles Vaccines Committee.

[No authors listed] [No authors listed] Practitioner. 1971 Apr;206(234):458-66. Practitioner. 1971. PMID: 4930718 Clinical Trial. No abstract available.

9

Higher risk of measles when the first dose of a 2-dose schedule of measles vaccine is given at 12-14 months versus 15 months of age.

De Serres G, Boulianne N, Defay F, Brousseau N, Benoît M, Lacoursière S, Guillemette F, Soto J, Ouakki M, Ward BJ, Skowronski DM. De Serres G, et al. Clin Infect Dis. 2012 Aug;55(3):394-402. doi: 10.1093/cid/cis439. Epub 2012 Apr 27. Clin Infect Dis. 2012. PMID: 22543023

10

[An outbreak of measles in a vaccinated community--a new situation].

Taranger J, Christenson B, Jodal U, Kjerstadius T, Lidin-Janson G. Taranger J, et al. Lakartidningen. 1990 Dec 12;87(50):4298, 4303. Lakartidningen. 1990. PMID: 2280630 Swedish. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed